Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

April 01, 2020; Volume 97,Issue 4

Articles

  • You have access
    Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill
    Xiaolei Xie, Guangan He and Zahid H. Siddik
    Molecular Pharmacology April 2020, 97 (4) 237-249; DOI: https://doi.org/10.1124/mol.119.117564
  • You have access
    Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action
    A. Ashna, D.F. van Helden, C. dos Remedios, P. Molenaar and D.R. Laver
    Molecular Pharmacology April 2020, 97 (4) 250-258; DOI: https://doi.org/10.1124/mol.119.117721
  • You have access
    Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer
    Ying Zhou, Chaonan Ye, Yan Lou, Junqing Liu, Sheng Ye, Lu Chen, Jinxiu Lei, Suhang Guo, Su Zeng and Lushan Yu
    Molecular Pharmacology April 2020, 97 (4) 259-266; DOI: https://doi.org/10.1124/mol.119.118216
  • You have access
    Voltage Dependence of Prostanoid Receptors
    Michael Kurz, Anna-Lena Krett and Moritz Bünemann
    Molecular Pharmacology April 2020, 97 (4) 267-277; DOI: https://doi.org/10.1124/mol.119.118372
  • You have access
    Knockdown of Long Noncoding RNAs Hepatocyte Nuclear Factor 1α Antisense RNA 1 and Hepatocyte Nuclear Factor 4α Antisense RNA 1 Alters Susceptibility of Acetaminophen-Induced Cytotoxicity in HepaRG Cells
    Liming Chen, Pei Wang, José E. Manautou and Xiao-bo Zhong
    Molecular Pharmacology April 2020, 97 (4) 278-286; DOI: https://doi.org/10.1124/mol.119.118778
  • You have access
    Structures of Mycobacterium tuberculosis Penicillin-Binding Protein 3 in Complex with Five β-Lactam Antibiotics Reveal Mechanism of Inactivation
    Zuokun Lu, Han Wang, Aili Zhang, Xiang Liu, Weihong Zhou, Cheng Yang, Luke Guddat, Haitao Yang, Christopher J. Schofield and Zihe Rao
    Molecular Pharmacology April 2020, 97 (4) 287-294; DOI: https://doi.org/10.1124/mol.119.118042
  • Neutral Diclofenac Causes Remarkable Changes in Phosphatidylcholine Bilayers: Relevance for Gastric Toxicity Mechanisms
    Open Access
    Neutral Diclofenac Causes Remarkable Changes in Phosphatidylcholine Bilayers: Relevance for Gastric Toxicity Mechanisms
    Catarina Pereira-Leite, Sarah K. Jamal, João P. Almeida, Ana Coutinho, Manuel Prieto, Iolanda M. Cuccovia, Cláudia Nunes and Salette Reis
    Molecular Pharmacology April 2020, 97 (4) 295-303; DOI: https://doi.org/10.1124/mol.119.118299
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 97 (4)
Molecular Pharmacology
Vol. 97, Issue 4
1 Apr 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics